China Regenerative Medicine International Limited (HKG:8158)
Hong Kong · Delayed Price · Currency is HKD 0.3850
-0.0150 (-3.75%)
Jun 1, 2026, 3:12 PM HKT
HKG:8158 Cash Flow Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 27.53 | 17.75 | -107.7 | 4.56 | 51.83 |
Depreciation & Amortization | 9.86 | 10.96 | 11.32 | 5.39 | 0.08 |
Loss (Gain) From Sale of Assets | - | - | - | - | 38.49 |
Stock-Based Compensation | - | - | - | - | 2.16 |
Provision & Write-off of Bad Debts | - | - | - | - | -41.35 |
Other Operating Activities | -27.94 | -11.46 | 83.97 | 10.99 | 9.91 |
Change in Accounts Receivable | -4.47 | 0.57 | -1.13 | 0.14 | -0.13 |
Change in Inventory | -1.8 | 0.21 | -0.16 | 0.1 | 0.06 |
Change in Accounts Payable | -0.84 | 1.37 | 2.42 | -0.03 | -8.14 |
Change in Unearned Revenue | 15.37 | -13.89 | 20.35 | -9.37 | 72.59 |
Change in Other Net Operating Assets | -13.61 | 12.79 | 1.72 | -24.21 | -90.02 |
Operating Cash Flow | 4.09 | 18.3 | 10.79 | -12.43 | -3.02 |
Operating Cash Flow Growth | -77.63% | 69.65% | - | - | - |
Capital Expenditures | -0.07 | -0.63 | -0.27 | -2.59 | -0.81 |
Divestitures | - | - | - | - | 10.07 |
Other Investing Activities | 0 | 0.01 | 0.01 | 0 | 0.01 |
Investing Cash Flow | -0.07 | -0.62 | -0.26 | -2.59 | 9.27 |
Short-Term Debt Issued | 10.42 | - | - | - | - |
Long-Term Debt Issued | 33.08 | 21.18 | 7.09 | 20.19 | 9.66 |
Total Debt Issued | 43.5 | 21.18 | 7.09 | 20.19 | 9.66 |
Long-Term Debt Repaid | -61.86 | -18.33 | -14.45 | -12.86 | -10.87 |
Total Debt Repaid | -61.86 | -18.33 | -14.45 | -12.86 | -10.87 |
Net Debt Issued (Repaid) | -18.36 | 2.85 | -7.36 | 7.32 | -1.22 |
Other Financing Activities | -0.75 | -0.49 | -0.98 | - | -0.17 |
Financing Cash Flow | -19.11 | 2.37 | -8.34 | 7.32 | -1.39 |
Foreign Exchange Rate Adjustments | 0.55 | -0.68 | -0.7 | -0.38 | 0.3 |
Net Cash Flow | -14.53 | 19.37 | 1.49 | -8.08 | 5.16 |
Free Cash Flow | 4.02 | 17.68 | 10.52 | -15.03 | -3.83 |
Free Cash Flow Growth | -77.23% | 68.11% | - | - | - |
Free Cash Flow Margin | 5.59% | 19.51% | 15.13% | -36.17% | -1.35% |
Free Cash Flow Per Share | 0.01 | 0.06 | 0.04 | -0.05 | -0.01 |
Cash Interest Paid | 0.75 | 0.49 | 0.98 | 0.78 | 0.74 |
Levered Free Cash Flow | -21.02 | 69.98 | 100.04 | -0.75 | -122.4 |
Unlevered Free Cash Flow | -20.27 | 70.69 | 100.65 | -0.26 | -121.94 |
Change in Working Capital | -5.35 | 1.06 | 23.2 | -33.37 | -25.65 |